Literature DB >> 16315124

Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study.

B Müllhaupt1, K Truninger, R Ammann.   

Abstract

BACKGROUND AND AIM: This prospective study aimed to investigate the impact of etiology on the pain profile in relation to alterations of function and morphology from early to advanced chronic pancreatitis (CP).
METHODS: Our mixed medico-surgical cohort comprised 265 patients with alcoholic (ACP), 21 with idiopathic "juvenile" (IJCP), 46 with idiopathic "senile" (ISCP) and 11 with hereditary CP (HPCP). The patients were followed regularly from onset of disease according to the protocol published previously.
RESULTS: Males predominated in ACP, IJCP, ISCP (> 71%) but not in HP (46%). Age at onset (median) was 10, 23, 36 and 62 years in HP, IJCP, ACP and ISCP, respectively. Follow-up from disease onset ranged from 14 to 36 years. The progression to late-stage CP, documented by exocrine insufficiency (86-100%) and calcification (80-91%) lasted 2 to 5-fold longer in HP/IJCP compared to ACP. Early stage CP, characterized by recurrent pancreatitis prevailed in > or = 90% of patients, except for those with ISCP (48%), and lasted up to 5-fold longer in HP/IJCP compared to ACP. Surgery for severe pain was required for ACP/IJCP in 57% of the patients compared to < 27% in HP/ISCP. Permanent pain relief regularly occurred in late-stage CP irrespective of etiology and surgery.
CONCLUSION: The clinical profile of the 4 "etiological" subgroups is predictably different in the painful early (precalcific) CP stage.

Entities:  

Mesh:

Year:  2005        PMID: 16315124     DOI: 10.1055/s-2005-858733

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  15 in total

1.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 2.  Is it necessary to distinguish between alcoholic and nonalcoholic chronic pancreatitis?

Authors:  Julia Mayerle; Markus M Lerch
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 3.  Do the diagnostic criteria differ between alcoholic and nonalcoholic chronic pancreatitis?

Authors:  Rudolf W Ammann; Beat Mullhaupt
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 4.  Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis.

Authors:  A K Waljee; M J Dimagno; B U Wu; P S Schoenfeld; D L Conwell
Journal:  Aliment Pharmacol Ther       Date:  2008-11-08       Impact factor: 8.171

Review 5.  Endoscopic therapy in chronic pancreatitis.

Authors:  Damien Meng Yew Tan; Stuart Sherman
Journal:  Korean J Intern Med       Date:  2011-11-28       Impact factor: 2.884

6.  The Chronic Pancreatitis International Classification of Diseases, Ninth Revision, Clinical Modification Code 577.1 Is Inaccurate Compared With Criterion-Standard Clinical Diagnostic Scoring Systems.

Authors:  Naveen G Reddy; Sharad Nangia; Matthew J DiMagno
Journal:  Pancreas       Date:  2016-10       Impact factor: 3.327

Review 7.  New advances in acute pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2007-09       Impact factor: 3.287

8.  Right atrium floating thrombus and bilateral pulmonary embolism in a patient with pancreatic pseudocyst.

Authors:  Diana Alexandra Cherata; Ionut Donoiu; Oana Mirea; Rodica Diaconu; Octavian Istratoaie
Journal:  J Cardiol Cases       Date:  2018-05-26

Review 9.  Pain in chronic pancreatitis: a salutogenic mechanism or a maladaptive brain response?

Authors:  Felipe Fregni; Alvaro Pascual-Leone; Steven D Freedman
Journal:  Pancreatology       Date:  2007-09-25       Impact factor: 3.996

10.  Nitric oxide pathways and evidence-based perturbations in acute pancreatitis.

Authors:  Matthew J DiMagno
Journal:  Pancreatology       Date:  2007-09-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.